379 related articles for article (PubMed ID: 20166083)
1. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
3. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
[TBL] [Abstract][Full Text] [Related]
5. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Playford EG; Webster AC; Sorrell TC; Craig JC
Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
[TBL] [Abstract][Full Text] [Related]
6. Systemic antifungal drugs for invasive fungal infection in preterm infants.
Clerihew L; McGuire W
Cochrane Database Syst Rev; 2004; (1):CD003953. PubMed ID: 14974045
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
8. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
Playford EG; Webster AC; Sorell TC; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
[TBL] [Abstract][Full Text] [Related]
9. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
Playford EG; Webster AC; Sorrell TC; Craig JC
J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
[TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
[TBL] [Abstract][Full Text] [Related]
11. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
Pienaar ED; Young T; Holmes H
Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD003940. PubMed ID: 21069679
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia.
Johansen HK; Gøtzsche PC
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD000969. PubMed ID: 25188673
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia.
Johansen HK; Gotzsche PC
Cochrane Database Syst Rev; 2000; (3):CD000969. PubMed ID: 10908480
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Clerihew L; Austin N; McGuire W
Cochrane Database Syst Rev; 2007 Oct; (4):CD003850. PubMed ID: 17943803
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Johansen HK; Gøtzsche PC
Cochrane Database Syst Rev; 2002; (2):CD000239. PubMed ID: 12076388
[TBL] [Abstract][Full Text] [Related]
17. Antifungal therapy for newborn infants with invasive fungal infection.
Clerihew L; McGuire W
Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD003953. PubMed ID: 22696338
[TBL] [Abstract][Full Text] [Related]
18. An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.
Ellis M; Frampton C; Joseph J; Alizadeh H; Kristensen J; Hauggaard A; Shammas F
J Med Microbiol; 2006 Oct; 55(Pt 10):1357-1365. PubMed ID: 17005784
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Austin N; McGuire W
Cochrane Database Syst Rev; 2013 Apr; (4):CD003850. PubMed ID: 23633315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
